LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 33

Search options

  1. Article: Urgences en hématologie maligne/ Emergencies in malignant hematology

    Picard, Muriel / Sifontes, Stein Silva / Récher, Christian / Bertoli, Sarah

    Médecine intensive réanimation

    2023  Volume 32, Issue 1, Page(s) 99

    Language French
    Document type Article
    ZDB-ID 2870987-1
    ISSN 2496-6142
    Database Current Contents Medicine

    More links

    Kategorien

  2. Article ; Online: Open abdominal vacuum pack technique for the management of severe abdominal complications after cytoreductive surgery in ovarian cancer.

    Navarro, Anne-Sophie / Gomez, Carlos Martinez / Angeles, Martina Aida / Fuzier, Régis / Ruiz, Jean / Picard, Muriel / Martinez, Alejandra / Ferron, Gwénaël

    Gynecologic oncology

    2023  Volume 170, Page(s) 108–113

    Abstract: Introduction: The aim of this study was to evaluate the indications and management of grade III-IV postoperative complications in patients requiring vacuum-assisted open abdomen after debulking surgery for ovarian carcinomatosis.: Methods: ... ...

    Abstract Introduction: The aim of this study was to evaluate the indications and management of grade III-IV postoperative complications in patients requiring vacuum-assisted open abdomen after debulking surgery for ovarian carcinomatosis.
    Methods: Retrospective study of prospectively collected data from patients who underwent a cytoreductive surgery by laparotomy for an epithelial ovarian cancer that required postoperative management of an open abdomen. An abdominal vacuum-assisted wound closure (VAWC) was applied in cases of abdominal compartmental syndrome (ACS) or intra-abdominal hypertension, to prevent ACS. The fascia was closed with a suture or a biologic mesh. The primary aim was to achieve primary fascial closure. Secondary outcomes considered included complications of cytoreductive surgery (CRS) and open abdominal wounds (hernia, fistula).
    Results: Two percent of patients who underwent CRS required VAWC during the study's patient inclusion period. VAWC indications included: (i) seven cases of gastro-intestinal perforation, (ii) three necrotic enterocolitis, (iii) two intestinal ischemia, (iv) three anastomotic leakages and (v) four intra-abdominal hemorrhages. VAWC was used to treat indications (i) to (iv) (which represented 73.7% of cases), to prevent compartmental syndrome. Primary fascia closure was achieved in 100% of cases, in four cases (21.0%) a biologic mesh was used. Median hospital stay was 65 days (range: 18-153). Four patients died during hospitalization, three of these within 30 days of VAWC completion.
    Conclusion: VAWC for managing open abdominal wounds is a reliable technique to treat surgical post-CRS complications in advanced ovarian cancer and reduces the early post-operative mortality in cases presenting with severe complications.
    MeSH term(s) Humans ; Female ; Cytoreduction Surgical Procedures ; Retrospective Studies ; Abdomen/surgery ; Abdominal Injuries/etiology ; Abdominal Injuries/surgery ; Postoperative Complications/etiology ; Ovarian Neoplasms/etiology ; Carcinoma, Ovarian Epithelial/etiology ; Biological Products ; Negative-Pressure Wound Therapy/adverse effects ; Negative-Pressure Wound Therapy/methods ; Abdominal Wound Closure Techniques
    Chemical Substances Biological Products
    Language English
    Publishing date 2023-01-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 801461-9
    ISSN 1095-6859 ; 0090-8258
    ISSN (online) 1095-6859
    ISSN 0090-8258
    DOI 10.1016/j.ygyno.2023.01.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France.

    Demonchy, Jordane / Biard, Lucie / Clere-Jehl, Raphaël / Wallet, Florent / Mokart, Djamel / Moreau, Anne-Sophie / Argaud, Laurent / Verlhac, Camille / Pène, Frédéric / Lautrette, Alexandre / Bige, Naïke / de Jong, Audrey / Canet, Emmanuel / Quenot, Jean-Pierre / Issa, Nahéma / Zerbib, Yoann / Bouard, Inès / Picard, Muriel / Zafrani, Lara

    Emerging infectious diseases

    2024  Volume 30, Issue 2

    Abstract: Invasive fusariosis can be life-threatening, especially in immunocompromised patients who require intensive care unit (ICU) admission. We conducted a multicenter retrospective study to describe clinical and biologic characteristics, patient outcomes, and ...

    Abstract Invasive fusariosis can be life-threatening, especially in immunocompromised patients who require intensive care unit (ICU) admission. We conducted a multicenter retrospective study to describe clinical and biologic characteristics, patient outcomes, and factors associated with death and response to antifungal therapy. We identified 55 patients with invasive fusariosis from 16 ICUs in France during 2002----2020. The mortality rate was high (56%). Fusariosis-related pneumonia occurred in 76% of patients, often leading to acute respiratory failure. Factors associated with death included elevated sequential organ failure assessment score at ICU admission or history of allogeneic hematopoietic stem cell transplantation or hematologic malignancies. Neither voriconazole treatment nor disseminated fusariosis were strongly associated with response to therapy. Invasive fusariosis can lead to multiorgan failure and is associated with high mortality rates in ICUs. Clinicians should closely monitor ICU patients with a history of hematologic malignancies or stem cell transplantation because of higher risk for death.
    MeSH term(s) Humans ; Fusariosis/drug therapy ; Fusariosis/epidemiology ; Retrospective Studies ; Intensive Care Units ; France/epidemiology ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/therapy ; Multicenter Studies as Topic
    Language English
    Publishing date 2024-01-29
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid3002.231221
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient.

    Beziat, Guillaume / Tavitian, Suzanne / Picard, Muriel / Faguer, Stanislas / Recher, Christian / Huguet, Françoise

    Case reports in hematology

    2019  Volume 2019, Page(s) 9086570

    Abstract: L-asparaginase is a key chemotherapeutic agent in acute lymphoblastic leukemia (ALL). It is also known for multiple and severe specific toxicities, without consensual management. We report the case of a 51-year-old man treated with L-asparaginase for ... ...

    Abstract L-asparaginase is a key chemotherapeutic agent in acute lymphoblastic leukemia (ALL). It is also known for multiple and severe specific toxicities, without consensual management. We report the case of a 51-year-old man treated with L-asparaginase for recently diagnosed T-cell ALL. During the treatment, he developed a coma due to multifactorial diffuse cerebral edema, by hepatic encephalopathy, cerebral venous thrombosis, and hyperammonemia, all linked to toxicity of L-asparaginase. Specific and innovative treatments were employed to manage these toxicities: supplementation with L-carnitine, thiamine, and pyridoxine for hepatic toxicity, perfusion of sodium benzoate to decrease ammonemia, and extrahepatic albumin-based dialysis sessions, along with anticoagulation. The patient improved within two weeks and is currently alive 13 months later, in first complete remission, without sequelae, on an alleviated chemotherapy regimen.
    Language English
    Publishing date 2019-11-20
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2627639-2
    ISSN 2090-6579 ; 2090-6560
    ISSN (online) 2090-6579
    ISSN 2090-6560
    DOI 10.1155/2019/9086570
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature.

    Branco, Benoît / Comont, Thibault / Ysebaert, Loïc / Picard, Muriel / Laurent, Camille / Oberic, Lucie

    European journal of haematology

    2019  Volume 103, Issue 4, Page(s) 444–448

    MeSH term(s) Alleles ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers ; Biopsy ; Female ; Histiocytic Sarcoma/diagnosis ; Histiocytic Sarcoma/drug therapy ; Histiocytic Sarcoma/genetics ; Humans ; Mutation ; Positron Emission Tomography Computed Tomography ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/genetics ; Tomography, X-Ray Computed ; Treatment Outcome ; Young Adult
    Chemical Substances Antineoplastic Agents ; Biomarkers ; Protein Kinase Inhibitors ; BRAF protein, human (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1)
    Language English
    Publishing date 2019-08-23
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 392482-8
    ISSN 1600-0609 ; 0902-4441
    ISSN (online) 1600-0609
    ISSN 0902-4441
    DOI 10.1111/ejh.13303
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Prise en charge du syndrome de neurotoxicité associée au traitement par cellules CAR-T chez l’adulte et l’enfant : recommandations de la SFGM-TC.

    Picard, Muriel / Sterin, Arthur / Bay, Jacques-Olivier / Courbon, Corinne / Moreau, Anne-Sophie / Paul, Franciane / Pochon, Cécile / Tudesq, Jean-Jacques / Vicente, Céline / Yakoub-Agha, Mathilde / Yakoub-Agha, Ibrahim

    Bulletin du cancer

    2022  Volume 110, Issue 2S, Page(s) S123–S131

    Abstract: The immune effector cell-associated syndrome (ICANS) has been described as the second most frequent specific complication following CAR-T cell therapy. The median time to the onset of neurological symptoms is five days after CAR-T infusion. ICANS can be ... ...

    Title translation Management of neurotoxicity following CAR-T cell therapy: Recommendations of the SFGM-TC.
    Abstract The immune effector cell-associated syndrome (ICANS) has been described as the second most frequent specific complication following CAR-T cell therapy. The median time to the onset of neurological symptoms is five days after CAR-T infusion. ICANS can be concomitant to cytokine release syndrome but often follows the resolution of the latter. However, 10 % of patients experience delayed onset after 3 weeks of CAR-T cell infusion. The duration of symptoms is usually short, around five days if an early appropriate treatment is given. Symptoms are heterogeneous, ranging from mild symptoms quickly reversible (alterations of consciousness, deterioration in handwriting) to more serious forms with seizures or even a coma. The ICANS severity is currently based on the ASTCT score. The diagnosis of ICANS is clinical but EEG, MRI and lumbar punction can help ruling out alternative diagnoses. The first line treatment consists of high-dose corticosteroids. During the twelfth edition of practice harmonization workshops of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), a working group focused its work on updating the SFGM-TC recommendations on the management of ICANS. In this review we discuss the management of ICANS and other neurological toxicities in patients undergoing of CAR-T cell therapy. These recommendations apply to commercial CAR-T cells, in order to guide strategies for the management neurological complications associated with this new therapeutic approach.
    MeSH term(s) Humans ; Receptors, Chimeric Antigen/therapeutic use ; Immunotherapy, Adoptive/adverse effects ; Bone Marrow Transplantation ; Cytokine Release Syndrome/etiology
    Chemical Substances Receptors, Chimeric Antigen
    Language French
    Publishing date 2022-01-31
    Publishing country France
    Document type Review ; English Abstract ; Journal Article
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2021.12.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Risk factors for gastric perforation after cytoreductive surgery in patients with peritoneal carcinomatosis: Splenectomy and increased body mass index.

    Angeles, Martina Aida / Martínez-Gómez, Carlos / Del, Mathilde / Migliorelli, Federico / Daix, Manon / Provendier, Anaïs / Picard, Muriel / Ruiz, Jean / Chantalat, Elodie / Leray, Hélène / Martinez, Alejandra / Gladieff, Laurence / Ferron, Gwénaël

    PloS one

    2021  Volume 16, Issue 3, Page(s) e0248205

    Abstract: Background: Gastric perforation after cytoreductive surgery (CRS) is an infrequent complication. There is lack of evidence regarding the risk factors for this postoperative complication. The aim of this study was to assess the prevalence of ... ...

    Abstract Background: Gastric perforation after cytoreductive surgery (CRS) is an infrequent complication. There is lack of evidence regarding the risk factors for this postoperative complication. The aim of this study was to assess the prevalence of postoperative gastric perforation in patients undergoing CRS for peritoneal carcinomatosis (PC) and to evaluate risk factors predisposing to this complication.
    Methods: We designed a unicentric retrospective study to identify all patients who underwent an open upfront or interval CRS after a primary diagnosis of PC of different origins between March 2007 and December 2018 at a French Comprehensive Cancer Center. The main outcome was the occurrence of postoperative gastric perforation.
    Results: Five hundred thirty-three patients underwent a CRS for PC during the study period and 13 (2.4%) presented a postoperative gastric perforation with a mortality rate of 23% (3/13). Neoadjuvant chemotherapy was administered in 283 (53.1%) patients and 99 (18.6%) received hyperthermic intraperitoneal chemotherapy (HIPEC). In the univariate analysis, body mass index (BMI), peritoneal cancer index, splenectomy, distal pancreatectomy, and histology were significantly associated with postoperative gastric perforation. After multivariate analysis, BMI (OR [95%CI] = 1.13 [1.05-1.22], p = 0.002) and splenectomy (OR [95%CI] = 26.65 [1.39-509.67], p = 0.029) remained significantly related to the primary outcome.
    Conclusions: Gastric perforation after CRS is a rare event with a high rate of mortality. While splenectomy and increased BMI are risk factors associated with this complication, HIPEC does not seem to be related. Gastric perforation is probably an ischemic complication due to a multifactorial process. Preventive measures such as preservation of the gastroepiploic arcade and prophylactic suture of the greater gastric curvature require further assessment.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Body Mass Index ; Cytoreduction Surgical Procedures/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Peritoneal Neoplasms/surgery ; Postoperative Complications/etiology ; Retrospective Studies ; Risk Factors ; Splenectomy ; Stomach/injuries ; Young Adult
    Language English
    Publishing date 2021-03-04
    Publishing country United States
    Document type Journal Article
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0248205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Genomic landscape of hyperleukocytic acute myeloid leukemia.

    Largeaud, Laetitia / Bertoli, Sarah / Bérard, Emilie / Tavitian, Suzanne / Picard, Muriel / Dufrechou, Stéphanie / Prade, Naïs / Vergez, François / Rieu, Jean Baptiste / Luquet, Isabelle / Sarry, Audrey / Huguet, Françoise / Ruiz, Jean / De Mas, Véronique / Delabesse, Eric / Récher, Christian

    Blood cancer journal

    2022  Volume 12, Issue 1, Page(s) 4

    MeSH term(s) Genomics ; Humans ; Leukemia, Myeloid, Acute/complications ; Leukemia, Myeloid, Acute/genetics ; Leukocyte Count ; Leukocytosis/complications ; Leukocytosis/genetics ; Mutation ; Retrospective Studies
    Language English
    Publishing date 2022-01-05
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2600560-8
    ISSN 2044-5385 ; 2044-5385
    ISSN (online) 2044-5385
    ISSN 2044-5385
    DOI 10.1038/s41408-021-00601-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia.

    Canali, Alban / Vergnolle, Inès / Bertoli, Sarah / Largeaud, Laetitia / Nicolau, Marie-Laure / Rieu, Jean-Baptiste / Tavitian, Suzanne / Huguet, Françoise / Picard, Muriel / Bories, Pierre / Vial, Jean Philippe / Lechevalier, Nicolas / Béné, Marie Christine / Luquet, Isabelle / Mansat-De Mas, Véronique / Delabesse, Eric / Récher, Christian / Vergez, François

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2022  Volume 29, Issue 1, Page(s) 134–142

    Abstract: Purpose: Acute myeloid leukemias (AML) are clonal diseases that develop from leukemic stem cells (LSC) that carry an independent prognostic impact on the initial response to induction chemotherapy, demonstrating the clinical relevance of LSC abundance ... ...

    Abstract Purpose: Acute myeloid leukemias (AML) are clonal diseases that develop from leukemic stem cells (LSC) that carry an independent prognostic impact on the initial response to induction chemotherapy, demonstrating the clinical relevance of LSC abundance in AML. In 2018, the European LeukemiaNet published recommendations for the detection of measurable residual disease (Bulk MRD) and suggested the exploration of LSC MRD and the use of multiparametric displays.
    Experimental design: We evaluated the performance of unsupervised clustering for the post-induction assessment of bulk and LSC MRD in 155 patients with AML who received intensive conventional chemotherapy treatment.
    Results: The median overall survival (OS) for Bulk+ MRD patients was 16.7 months and was not reached for negative patients (HR, 3.82; P < 0.0001). The median OS of LSC+ MRD patients was 25.0 months and not reached for negative patients (HR, 2.84; P = 0.001). Interestingly, 1-year (y) and 3-y OS were 60% and 39% in Bulk+, 91% and 52% in Bulk-LSC+ and 92% and 88% in Bulk-LSC-.
    Conclusions: In this study, we confirm the prognostic impact of post-induction multiparametric flow cytometry Bulk MRD in patients with AML. Focusing on LSCs, we identified a group of patients with negative Bulk MRD but positive LSC MRD (25.8% of our cohort) with an intermediate prognosis, demonstrating the interest of MRD analysis focusing on leukemic chemoresistant subpopulations.
    MeSH term(s) Humans ; Prognosis ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/drug therapy ; Induction Chemotherapy ; Neoplasm, Residual ; Stem Cells
    Language English
    Publishing date 2022-11-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-22-2237
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Complications des cellules CAR-T autres que les infections, CRS et ICANS : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).

    Pochon, Cécile / Courbon, Corinne / Bay, Jacques-Olivier / Moreau, Anne-Sophie / Paul, Franciane / Picard, Muriel / Sterin, Arthur / Tudesq, Jean-Jacques / Vicente, Céline / Yakoub-Agha, Mathilde / Yakoub-Agha, Ibrahim

    Bulletin du cancer

    2021  Volume 108, Issue 12S, Page(s) S98–S103

    Abstract: CAR-T cells are an innovative treatment for an increasing number of patients, particularly since the extension of their indication to mantle lymphoma and multiple myeloma. Several complications of CAR T-cell therapy, that were first described as ... ...

    Title translation Complications other than infections, CRS and ICANS following CAR T-cells therapy: Recommendations of the Francophone Society of bone marrow transplantation and cell therapy (SFGM-TC).
    Abstract CAR-T cells are an innovative treatment for an increasing number of patients, particularly since the extension of their indication to mantle lymphoma and multiple myeloma. Several complications of CAR T-cell therapy, that were first described as exceptional, have now been reported in series of patients, since its first clinical use in 2011. Among them, cardiac complications, delayed cytopenias, acute and chronic Graft versus Host Disease, and tumoral lysis syndrome are recognized as specific potent complications following CAR T-cells infusion. During the twelfth edition of practice harmonization workshops of the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC), a working group focused its work on the management of these complications with focuses the epidemiology, the physiopathology and the risk factors of these 4 side effects. Our recommendations apply to commercial CAR-T cells, in order to guide strategies for the management of complications associated with this new therapeutic approach.
    MeSH term(s) Graft vs Host Disease/epidemiology ; Graft vs Host Disease/etiology ; Heart Diseases/etiology ; Humans ; Immunotherapy, Adoptive/adverse effects ; Incidence ; Neutropenia/etiology ; Neutropenia/therapy ; Receptors, Chimeric Antigen ; Risk Factors ; T-Lymphocytes/transplantation ; Tumor Lysis Syndrome/etiology
    Chemical Substances Receptors, Chimeric Antigen
    Language French
    Publishing date 2021-11-19
    Publishing country France
    Document type Journal Article ; Practice Guideline
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2021.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top